Organon is a Dutch pharmaceutical company, recently acquired by Schering-Plough. With Organon we partner in the CTMM LeARN-project about Alzheimer Disease. Organon will search for new medicins against Alzheimer Disease. With our new "neuro-brain" module for the VP MicroLab, they will be able to analyse the effects of these new drugs in 3D data of real patients.
With Philips we also partner in the CTMM LeARN-project about Alzheimer Disease. Philips will develop new PET and MRI instruments using biomarkers to enhance the visualization of so-called " amyloid plagues" in the brains of Alzheimer patients. Virtual Proteins will develop a "neuro-brain" module for the VP MicroLab to enable scientists, radiologists and physicians to analyze this new data 3D in virtual reality.
DSM is a global supplier of chemical compounds for the pharmaceutical industry. Virtual Proteins and AIM (hardware assembly) recieved a grant from the OIL-project (LIOF, DSM & Syntens) to design and engineer part of the VP MicroLab hardware solution. DSM also gives valuable feedback about the latest VP MicroLab software.
Virtual Proteins recently joined the Life Sciences Limburg Communitee,The networking and information organisation for the Life Sciences sector in Limburg